PubMed

The Pharmaceutical Benefits Scheme 2003-2004.

Harvey KJ.

Aust New Zealand Health Policy. 2005 Jan 12;2(1):2.PMID: 15679896 [PubMed - as supplied by publisher]Related articlesFree article

Will the Australia-United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?

Harvey KJ, Faunce TA, Lokuge B, Drahos P.

Med J Aust. 2004 Sep 6;181(5):256-9.PMID: 15347273 [PubMed - indexed for MEDLINE]Related articlesFree article

Are Australians able to access new medicines on the pharmaceutical benefits scheme in a more or less timely manner? An analysis of pharmaceutical benefits advisory committee recommendations, 1999-2003.

Wonder MJ, Neville AM, Parsons R.

Value Health. 2006 Jul-Aug;9(4):205-12.PMID: 16903989 [PubMed - indexed for MEDLINE]Related articles

The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.

Hynd A, Roughead EE, Preen DB, Glover J, Bulsara M, Semmens J.

Pharmacoepidemiol Drug Saf. 2008 Nov;17(11):1091-9.PMID: 18942671 [PubMed - indexed for MEDLINE]Related articles

Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia.

Hynd A, Roughead EE, Preen DB, Glover J, Bulsara M, Semmens J.

Aust N Z J Public Health. 2009 Jun;33(3):246-52.PMID: 19630844 [PubMed - indexed for MEDLINE]Related articles

The Pharmaceutical Benefits Scheme and implications for paediatric prescribing.

Sinha Y, Brien JA, Craig JC.

J Paediatr Child Health. 2009 May 28. [Epub ahead of print]PMID: 19490409 [PubMed - as supplied by publisher]Related articles

Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal.

Faunce TA.

Aust New Zealand Health Policy. 2007 Jun 1;4:9.PMID: 17543114 [PubMed]Related articlesFree article

Evidence-based decision-making within Australia's pharmaceutical benefits scheme.

Lopert R.

Issue Brief (Commonw Fund). 2009 Jul;60:1-13.PMID: 19639714 [PubMed - indexed for MEDLINE]Related articles

The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes.

King MA, Roberts MS.

Pharm World Sci. 2007 Feb;29(1):39-42.PMID: 17268937 [PubMed - indexed for MEDLINE]Related articles

Free trade in pharmaceuticals.

Outterson MK.

Med J Aust. 2004 Sep 6;181(5):260-1.PMID: 15347274 [PubMed - indexed for MEDLINE]Related articlesFree article

New medicines in primary care: a review of influences on general practitioner prescribing.

Mason A.

J Clin Pharm Ther. 2008 Feb;33(1):1-10. Review.PMID: 18211610 [PubMed - indexed for MEDLINE]Related articles

Pharmaceutical policies: effects of cap and co-payment on rational drug use.

Austvoll-Dahlgren A, Aaserud M, Vist G, Ramsay C, Oxman AD, Sturm H, Kösters JP, Vernby A.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD007017. Review.PMID: 18254125 [PubMed - indexed for MEDLINE]Related articles

Evaluation of a national quality use of medicines service in Australia: an evolving model.

Beilby J, Wutzke SE, Bowman J, Mackson JM, Weekes LM.

J Eval Clin Pract. 2006 Apr;12(2):202-17.PMID: 16579830 [PubMed - indexed for MEDLINE]Related articles

Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme.

Robertson J, Walkom EJ, Henry DA.

Aust Health Rev. 2009 May;33(2):192-9.PMID: 19563308 [PubMed - in process]Related articles

Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy.

Faunce T, Doran E, Henry D, Drahos P, Searles A, Pekarsky B, Neville W.

Global Health. 2005 Oct 6;1:15.PMID: 16209703 [PubMed]Related articlesFree article

The UNESCO Bioethics Declaration 'social responsibility' principle and cost-effectiveness price evaluations for essential medicines.

Faunce TA.

Monash Bioeth Rev. 2005 Jul;24(3):10-9.PMID: 16302317 [PubMed - indexed for MEDLINE]Related articles

Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.

Doran E, Alexander Henry D.

J Public Health Policy. 2008 Apr;29(1):106-20.PMID: 18368023 [PubMed - indexed for MEDLINE]Related articles

Factors affecting the uptake of new medicines in secondary care - a literature review.

Chauhan D, Mason A.

J Clin Pharm Ther. 2008 Aug;33(4):339-48. Review.PMID: 18613851 [PubMed - indexed for MEDLINE]Related articles

The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines.

Lu CY, Williams KM, Day RO.

Aust New Zealand Health Policy. 2007 Mar 1;4:2.PMID: 17331230 [PubMed]Related articlesFree article

Improving access to medicines among clients of remote area Aboriginal and Torres Strait Islander Health Services.

Kelaher M, Dunt D, Taylor-Thomson D, Harrison N, O'Donoghue L, Barnes T, Anderson I.

Aust N Z J Public Health. 2006 Apr;30(2):177-83.PMID: 16681341 [PubMed - indexed for MEDLINE]Related articles